Trial Information
Measurement of Intratumoral Concentration of the Nontoxic Natural Compound Curcumin in Glioblastoma Patients
Inclusion Criteria:
- Patients harboring Glioblastoma
- Patient will undergo surgery
Exclusion Criteria:
- BMI > 30
- Liver and Kidney Function so compromised that medication is prescribed
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
Concentration of Curcumin in Glioblastoma
Outcome Description:
At the time of surgery
Outcome Time Frame:
At Tumor resection
Safety Issue:
No
Principal Investigator
Stephan Duetzmann
Investigator Role:
Principal Investigator
Investigator Affiliation:
Goethe University
Authority:
Regierungspräsidium Darmstadt: Germany
Study ID:
JohannWGUH_Curcumin-01
NCT ID:
NCT01712542
Start Date:
October 2012
Completion Date:
May 2013
Related Keywords:
- Patient Harboring Glioblastoma That Will Undergo Surgery
- Glioblastoma